| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_411539c66c0ebfadbe26b881f77b9a46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_382ccfc2ebebcaee15aa7cda4cee86bc |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2121-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7032
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H15-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7032
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02 |
| filingDate |
2012-11-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4e6f7243b768fb34572b6e50cd80310f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_76864bbd63468e75b06d040d52d85db9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_434770af18d9fe274a4572c6718bb96d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b9a83dd59f602ff355e280d30f2d5b38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a09751b1b33c2d883db6668d1eaee33e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8d966d98ebc0fd69cf54d69e75839f51 |
| publicationDate |
2014-08-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20140102701-A |
| titleOfInvention |
Keratoconjunctival protecting agent, or keratoconjunctival disorder inhibiting agent |
| abstract |
It is an object of the present invention to provide an anti-conjunctiva-protective agent or anti-conjunctiva inhibitory agent having an excellent effect of inhibiting each conjunctival disorder. The present invention includes the use of glucosyl glycerol as an active ingredient for glucosyl glycerol or the use of glucosyl glycerol for the manufacture of a medicament for inhibiting each conjunctival barrier or inhibiting each conjunctival barrier, To protect each conjunctiva, or to inhibit each conjunctival disorder. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018101517-A1 |
| priorityDate |
2011-11-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |